Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Phénotypage multidimensionnel vers un accompagnement nutritionnel préventif personnalisé pour les personnes âgées (MetabotypAGE)

Nouvelle stratégie de recherche participative et phénotypage multidimensionnel vers un soutien nutritionnel préventif personnalisé pour les personnes âgées

There is high inter-individual variability in the response to feeding, which is determined by multiple interacting factors such as age, sex, genotype, gut microbiota, eating behaviors, physical activity or even socio-demographic factors. Original studies have recently demonstrated the possibility of predicting the postprandial response to the diet of healthy individuals on the basis of in-depth phenotyping, and of offering them foods adapted to their own metabolic capacities according to their belonging to different groups of individuals defined on the basis of the similarity of their metabolic capacities. Due to different life trajectories, inter-individual variability could be amplified upon entry into the aging period, which could explain at least in part why traditional strategies for managing chronic age-related pathologies are insufficient. The investigators aim is to propose a new strategy to better understand inter-individual variability in the response to food in the elderly based on deep phenotyping.

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Description détaillée

During a first phase of the project, the investigators defined all the parameters that could be measured to realize a deep phenotyping of volunteers to establish "metabotypes" and have a better understanding of the variability in the response to food. These parameters include: kinetics of change in postprandial blood glucose over a period of 4 hours following home consumption of four types of test meals (composite nutritional test); and measurement of several blood parameters either in the post-absorptive state, or in the post-prandial state, either after test meals at home, or after a fat meal in the research facility: triglycerides, insulin, C-Reactive-Protein, metabolites through open metabolomics, albumin, fatty acids, cytokines, different gene expression. Through questionnaires or tests the investigators will also assess:

food habits and preferences (with a special focus on polyphenols), olfactory and taste abilities, physical activity, muscle functionality, body composition, peripheral endothelial function and microvascular stiffness, blood pressure, oral status, cognitive function, stress and depression status, intestinal function, psycho-socio-economic status. Finally, the investigators will constitute a collection of blood, white cell, plasma, serum, saliva, urine and stool samples.

Type d'étude

Interventionnel

Inscription (Réel)

180

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Clermont-Ferrand, France, 63009
        • Plateforme d'Exploration de la Mobilité (CHU Clermont-Ferrand)
      • Clermont-Ferrand, France, 63100
        • Centre de Recherche en Odontologie Clinique, Faculté de Chirurgie Dentaire
    • France
      • Clermont-Ferrand, France, France, 63000
        • Pic / Cic-Inserm 1405

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

60 ans à 75 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • - Subject with grip strength (assessed with a dynamometer) ≥16kg for women and ≥26 kg for men.
  • 21 ≤ BMI ≤35
  • Participant living in a rural or peri-urban area or city dweller, according to the population density grid of the Territorial Observatory (categories 3, 2 or 1 respectively).
  • Cognitively able to perform tests and answer questionnaires according to the judgment of the recruiting doctor and on the basis of the Mini-Mental State Examination (MMSE)
  • Available to carry out the entire protocol
  • Biological assessment considered by the investigator as compatible with participation in the study,
  • Subject agreeing to give written consent, and registration in the national file of volunteers who lend themselves to research
  • Person subject to a social security system.

Exclusion Criteria:

  • - Diabetes treated
  • Sub-acute pathology (flu, gastroenteritis, bacterial infection, etc.) or trauma (fracture, surgical intervention, etc.) in the 30 days preceding inclusion.
  • Hepatocellular insufficiency,
  • Heart failure with decompensation,
  • Renal insufficiency (clearance <30 ml/min)
  • Chronic anti-inflammatory treatment, long-term corticosteroid therapy > 1 month, infiltrations
  • Antibiotic treatment within 30 days prior to recruitment
  • Progressive pathology at the time of inclusion (cancer, etc.)
  • Gastrointestinal pathology deemed incompatible with the protocol
  • Eating habits incompatible with the protocol (allergies, test food intolerances/aversions, vegan diets, ketogenic diets, etc.)
  • Unstabilized thyroid diseases
  • Intense physical activity (activity causing shortness of breath and sweating) > 10 hours per week
  • Person who is in a period of exclusion on the National File of Healthy Volunteers
  • Subject presenting a psychiatric pathology or cognitive disorders making them incapable of giving informed consent.
  • Subject under guardianship, curatorship, deprived of freedoms or under the protection of justice

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Non dependant 60 to 75 year-old men and women

Deep phenotyping, including metabolic response to nutritional tests.

Metabolic responses to several test meals

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Characterize the inter-individual variability of the blood glucose postprandial response
Délai: Within the first month of study realization

Kinetics of change in postprandial blood glucose over a period of 4 hours following home consumption of four types of test meals by continuously monitoring blood glucose

Within the first month of study realization

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Questionnaires about food habits and preferences (with a special focus on polyphenols)
Délai: Within the three months of study realization

The investigators' objective is to have a good understanding of eating habits: estimation of precise food intake over three days but also long-term eating habits, preferences for sweet foods, salty foods, fatty foods. Participants will also be questioned about their general appetite, their neophobia, their culinary habits. An effort will be made to estimate polyphenol intake through specific questions.

Within the three months of study realization
Test to assess taste abilities
Délai: Within the first week of study realization

The participants will be offered drinks containing either water (n=2) or salted water (n=8), with various concentrations of salt. The objective is to determine which drinks contain salt or not. The score will vary from 0 (only bad answers) to 8 (only good answers). A score of 8 thus means that the taste abilities are good.

Within the first week of study realization
Test to assess olfactory abilities
Délai: Within the first week of study realization

Six groups of 4 vials will be presented to the participants. For each group of 4, only one vial has an odor. The first step will be to find the vial that does contain an odor. Then, the participant will have to identify the odor, choosing among 4 proposed odor. The score will increase with the number of vial found and the number of correct odor identification. It will thus vary from 0 to 8. If a participant has a score of 8, it means that he could detect each time in which vial there was an odor, and could each time identify the odor. Thus a score of 8 denotes very good olfactory abilities.

Within the first week of study realization
Time to walk 4 meters
Délai: Within the first two months of study realization

The time to walk 4 m will be measured.

Within the first two months of study realization
Time to stand up 5 times from a chair
Délai: Within the first two months of study realization

The time to stand up 5 times from a chair will be measured.

Within the first two months of study realization
Maximum tolerated muscle power
Délai: Within the first two months of study realization

The maximum tolerated muscle power will be measured on a cycloergometer

Within the first two months of study realization
Maximal isometric strength
Délai: Within the first two months of study realization

The maximal isometric strength of the quadriceps will be measured on an isometric measuring bench.

Within the first two months of study realization
Questionnaires about usual physical activity
Délai: Within the first two months of study realization

The objective is to assess the amount of time usually spent by the participant for physical activity and for sedentary activities, the intensity of activities, through 28 questions. This questionnaire will give a categorical score, with 3 levels of physical activity: 1) Low: no physical activity or only low intensity activities. 2) Moderate: 3 or more days of intense activity lasting at least 20 min per day, or 5 days or more of moderate intensity activity and/or walking for at least 30 minutes per day, or 5 days or more of activity combining walking, moderate or high intensity activities. 3) Intense activity at least 3 days per week or 7 days or more of activity combining walking, moderate or high intensity activities

Within the first two months of study realization
Measurement of total body lean mass (kg)
Délai: Within the first two months of study realization

Lean body mass will be measured by multi frequency electrical bio impedance (Bodystat QuadScan 4000). A weak electric current is delivered to the subject through electrodes, and the voltage is measured in order to calculate impedance (resistance and reactance) of the body. Most body water is stored in muscle. Therefore, if a person is more muscular there is a high chance that the person will also have more body water, which leads to lower impedance. Using the weight of the participant, through calibration curves, the system then calculates total body water, total body fat mass, and total body lean mass.

Within the first two months of study realization
Measurement of total body fat mass (kg)
Délai: Within the first two months of study realization

Fat body mass will be measured by multi frequency electrical bio impedance (Bodystat QuadScan 4000). A weak electric current is delivered to the subject through electrodes, and the voltage is measured in order to calculate impedance (resistance and reactance) of the body. Most body water is stored in muscle. Therefore, if a person is more muscular there is a high chance that the person will also have more body water, which leads to lower impedance. Using the weight of the participant, through calibration curves, the system then calculates total body water, total body fat mass, and total body lean mass.

Within the first two months of study realization
Measurement of peripheral endothelial function (RHI, %)
Délai: Within the first week of study realization

Peripheral endothelial function of the participants will be assessed by tonometry using the Endo-PAT X system (Itamar Medical Ltd) before and after induction of post-occlusive reactive hyperemia. Endothelium-induced changes in vascular tone are measured at the fingertip using a pair of single-use plethysmographic sensors. The result obtained is the Reactive Hyperemia Index (RHI, %) which corresponds to the ratio between the amplitudes of the PAT® (Peripheral Arterial Tonometry) signal during hyperemia and the basal amplitudes of the occluded side, normalized by the values of the control arm. The values will be considered as normal if inferior to 1.67, and abnormal if higher than 1.67.

Within the first week of study realization
Measurement of microvascular stiffness (Augmentation Index)
Délai: Within the first week of study realization

Microvascular stiffness (=Augmentation Index) of the participants will be assessed by tonometry using the Endo-PAT X system (Itamar Medical Ltd). Augmentation Index (AI) will be calculated from the shape of the pulse wave recorded in basal conditions. This measurement is a recognized marker of cardiovascular risk. The AI value is inversely proportional to the stiffness of the vessels. The scale of the measurement is the following:

Values between 20-80: healthy degree of arterial flexibility. Values between 81-100 : increased cardiovascular risk Values over 100: high cardiovascular risk.

Within the first week of study realization
Assessment of oral status
Délai: Within the first two months of study realization.

Oral status will be assessed through the Nordic Orofacial Test - Screening (NOT-S), which is a screening and evaluation tool for orofacial motor dysfunctions and disorders. It includes two parts: 1) "Maintenance" part containing 6 sections: sensory function, breathing, habits, chewing and swallowing, drooling, and dry mouth (I-VI); 2) "Examination" part comprising 6 sections: face at rest, nasal breathing, facial expression, function of the masticatory muscles and jaws, oral motor functions, and articulation of speech. The NOT-S total score ranges from 0 (no dysfunction) to 12 (high dysfunction). For each section, from the moment the subject answers "Yes" to one of the questions, the box is checked and results in a score of 1 in the last right column of the questionnaire.

Within the first two months of study realization.
Assessment of cognitive function
Délai: Within the first week of study realization

The cognitive abilities of the participants will be assessed using the CANTAB®, using a computer under supervision. This method makes it possible to assess 1) episodic memory; 2) verbal recognition memory, that is, immediate and delayed memory for verbal information; 3) Spatial working memory, which requires the retention and manipulation of visuospatial information. 4) The spatial span task (CANTAB spatial spam), which evaluates the maximum amount of information that the subject is capable of recalling after a single presentation.

Within the first week of study realization
Assessment of depression status
Délai: Within the first week of study realization.

Participants' depressive nature will be assessed using the Geriatric Depression Scale (GDS) test. It is a self-questionnaire which contains 15 items, each with a binary Yes-No response. It is a commonly used tool to assess the presence of depressive symptoms in older adults. A score of 0 to 5 is considered normal. A score between 5 and 9 indicates a high likelihood of depression, and a score between 10 and 15 almost always indicates depression.

Within the first week of study realization.
Assessment of socio-economic status
Délai: Within the three months of study realization

The socio-economic status of participants will be assessed using the EPICES scale (Évaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé) which was developed in France by the National Institute of Prevention and Education for Health . This scale is used in public health to assess the social precariousness of individuals, which takes into account the multidimensional nature of precariousness. The main interest of the EPICES score consists of understanding populations which, while escaping the traditional administrative indicators of precariousness, present the same health risks. The EPICES score is based on 11 questions which summarize 90% of a subject's precarious situation. The answer to each question is assigned a coefficient, the sum of the 11 answers gives the EPICES score. The score is continuous, it varies from 0 (absence of precariousness) to 100 (maximum of precariousness).

Within the three months of study realization
Assessment of self-esteem
Délai: Within the three months of study realization

Participants' self-esteem will be assessed using the Rosenberg Self-Esteem Scale. It is a psychometric tool widely used in psychology research, social sciences and clinical settings. It consists of 10 questions to which respondents are asked to indicate their degree of agreement or disagreement using a 4-point Likert scale, ranging from "strongly disagree" to "strongly agree". The questions are designed to assess overall self-perception and personal esteem. The score between 10 and 40 which are interpreted according to specific thresholds.Higher scores indicate higher self-esteem.

Within the three months of study realization
Assessment of intestinal function
Délai: Within the first month of study realization

To have a better understanding of the characteristics of the participants' intestinal function, they will have to complete an intestinal transit diary. Such a diary is a tool used to record a person's stool habits and characteristics over a period of time. It is often used in the field of gastroenterology and nutrition to assess the functioning of the digestive system. Participants will note every day for 15 days: the frequency of stools, noting each time the time they had a bowel movement, as well as the consistency of stools based on the Bristol visual scale. which categorizes 7 types of stools, ranging from the hardest to the softest. Experts consider types 1 and 2 to be uncharacteristically hard and indicative of constipation, while types 6 and 7 are unusually loose and may indicate diarrhea. Medical professionals generally consider types 3, 4, and 5 to be the most typical. Overall, a qualitative assessment of intestinal function will be made, with no calculated score.

Within the first month of study realization
Stool collection
Délai: Within the first month of study realization

One sample of stool will be taken and analyzed by metagenomic.

Within the first month of study realization
Measurement of plasma insulin levels (micro U / mL)
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state, 2) after the ingestion of 4 standards test meals, 3) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization
Measurement of plasma triglycerides levels (mg / dL)
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state, 2) after the ingestion of 4 standards test meals, 3) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization
Measurement of plasma C Reactive Protein (mg / L)
Délai: Within the first two months of study realization

These measurements will be made in the post-absorptive state.

Within the first two months of study realization
Measurement of plasma amino acid levels (µMol)
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state 2) after the ingestion of a protein rich test meal.

Within the first two months of study realization
Measurement of plasma metabolite through open metabolomics
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state 2) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization
Measurement of plasma free fatty acids (mg / L)
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state 2) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization
Measurement of plasma cytokines (U / L)
Délai: Within the first two months of study realization

These measurements will be made 1) in the post-absorptive state 2) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization
Measurement of plasma albumin (g / L)
Délai: Within the first two months of study realization

These measurements will be made in the post-absorptive state

Within the first two months of study realization
Measurement of various gene expression in peripheral blood mononuclear cells isolated from blood samples.
Délai: Within the first two months of study realization

These measurements will be made in the post-absorptive state

Within the first two months of study realization
Measurement of plasma oxylipins (nmol / L)
Délai: Within the first two months of study realization.

These measurements will be made 1) in the post-absorptive state 2) after the ingestion of a sweet and fatty meal.

Within the first two months of study realization.
Measurement of immune responsiveness (whole blood oxylipin and cytokine responses to immune stimulation).
Délai: Within the first two months of study realization.

These measurements will be made in the post-absorptive state.

Within the first two months of study realization.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Gisèle Pichering, Pr, Centre d'Investigation Clinique

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

14 février 2024

Achèvement primaire (Réel)

30 octobre 2026

Achèvement de l'étude (Réel)

30 octobre 2026

Dates d'inscription aux études

Première soumission

10 novembre 2023

Première soumission répondant aux critères de contrôle qualité

1 décembre 2023

Première publication (Réel)

11 décembre 2023

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

6 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Sharing of all IPD that underlie results in a publication

Délai de partage IPD

Beginning 6 months after publication, and for as long as necessary after that

Critères d'accès au partage IPD

The data will be shared with any researcher who requests it by email following publication.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner